4 results
To assess the effect of oral UT-15C with PAH-approved oral monotherapy compared to placebo with PAHapproved oral monotherapy on time to first clinical worsening event (adjudicated), as defined by at least one of the events listed below:- Death (all…
To provide UT-15C for eligible subjects who participated in study protocol TDE-PH-310
This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 as a single agent (Phase Ia) or in combination with a checkpoint inhibitor targeting the PD-L1/PD-1 axis (Phase Ib) in patients with locally advanced or…
To study the effects of left ventricular unloading by means of IABP or Impella as an adjunct to ECMO versus ECMO alone on ECMO weaning success, mortality, quality of life and cost-effectiveness, and intermediating physiological parameters.…